News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CAPSUGEL Announces License Agreement With Teijin Pharma to Offer Vcaps(R) HPMC Capsules for Dry Powder Inhalation


10/8/2007 8:53:50 AM

PEAPACK, NJ--(Marketwire - October 08, 2007) - Capsugel, the leading global provider of dosage form solutions, has announced it will offer its Vcaps® HPMC (hypromellose) capsules for use in dry powder inhalation (DPI) products worldwide. The announcement follows the successful conclusion of a license agreement between Capsugel and Teijin Pharma Limited, part of the Teijin Group of Japan. The agreement grants Capsugel a license to Teijin's entire patent portfolio related to the use of HPMC capsules for inhalation products.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES